官方服务：
资源简介：
Osimertinib resistance mutation screening using modified Base editor
应用场景：
创建时间：
2025-01-15
相关数据集
CD69_CRISPR_SURF_GS_filtered_analysis
CRISPR-SURF analysis of tiling CRISPR screen data
NIAID Data Ecosystem80
DNAseq analysis of a genome-wide loss-of-function CRISPR/Cas9 library established in haploid human embryonic stem cells (hESCs)
The maintenance of pluripotency requires coordinated expression of a set of essential genes. Using our recently established haploid human pluripotent stem cells (hPSCs), we generated a genome-wide los
NIAID Data Ecosystem40
Results for DESeq2 differential expression analysis for 5 validation RNA-seq experiments of candidate sgRNA against safe-harbor controls.
baseMean: mean of normalized counts across all samples, log2FoldChange: log2 fold-change of candidate sgRNA over safe-harbor sgRNA read counts, lfcSE: standard error estimate of log2 fold-change, pval
Figshare2023-03-16 更新30
Table S5 from Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations
Results of LentiMutate on BCR-ABL and imatinib in the K562 cell line. Values shown are the averages of two biological replicates. The fold enrichment of "All nucleotides" is the sum of substitution ra
NIAID Data Ecosystem50
genome-wide CRISPR/Cas9 screen using survival to a NET-inducing stimulus
PLB-985 human myeloid cell line, differentiated (in RPMI 2.5% FCS, 0.5% dimethylformamide, P/S and glutamine) for 7 days. Mock-treated and PMA-stimulated for 16h to induce cell death via NET formation
NIAID Data Ecosystem30
